Interim analysis of data from a long-term, extension trial of tafamidis meglumine in patients with transthyretin amyloid cardiomyopathy

被引：0
|
作者：
Elliott, P. [1 ]
Drachman, B. M. [2 ]
Gottlieb, S. S. [3 ]
Hoffman, J. E. [4 ]
Hummel, S. L. [5 ]
Lenihan, D. J. [6 ]
Ebede, B. [7 ]
Gundapaneni, B. [8 ]
Schwartz, J. H. [9 ]
Sultan, M. B. [9 ]
Shah, S. J. [10 ]
机构：
[1] UCL, London, England
[2] Univ Penn, Penn Presbyterian Med Ctr, Hlth Syst, Philadelphia, PA USA
[3] Univ Maryland, Sch Med, Baltimore, MD 21201 USA
[4] Univ Miami, Miami, FL USA
[5] Univ Michigan, Ann Arbor, MI 48109 USA
[6] Washington Univ, Sch Med, St Louis, MO USA
[7] Pfizer Inc, Collegeville, PA USA
[8] Pfizer Inc, Groton, CT USA
[9] Pfizer Inc, New York, NY USA
[10] Northwestern Univ, Feinberg Sch Med, Div Cardiol, Dept Med, Chicago, IL 60611 USA
来源：
EUROPEAN HEART JOURNAL | 2019年 / 40卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1169
引用
收藏
页码：645 / 645
页数：1
相关论文
共 50 条
  • [1] Long-Term Survival With Tafamidis in Patients With Transthyretin Amyloid Cardiomyopathy
    Elliott, Perry
    Drachman, Brian M.
    Gottlieb, Stephen S.
    Hoffman, James E.
    Hummel, Scott L.
    Lenihan, Daniel J.
    Ebede, Ben
    Gundapaneni, Balarama
    Li, Benjamin
    Sultan, Marla B.
    Shah, Sanjiv J.
    CIRCULATION-HEART FAILURE, 2022, 15 (01) : E008193
  • [2] Long-term survival with tafamidis in patients with transthyretin amyloid cardiomyopathy
    Damy, T.
    Elliott, P.
    Gundapaneni, B.
    Tai, S. See
    Sultan, M. B.
    Drachman, B. M.
    EUROPEAN HEART JOURNAL, 2020, 41 : 2142 - 2142
  • [3] Health impact of tafamidis in transthyretin amyloid cardiomyopathy patients: an analysis from the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR-ACT) and the open-label long-term extension studies
    Rozenbaum, Mark H.
    Garcia, Andrea
    Grima, Daniel
    Tran, Diana
    Bhambri, Rahul
    Stewart, Michelle
    Li, Benjamin
    Heeg, Bart
    Postma, Maarten
    Masri, Ahmad
    EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES, 2022, 8 (05) : 529 - 538
  • [4] Long-term Survival Benefit of Tafamidis in Patients with Transthyretin Amyloid Cardiomyopathy
    Patel, Jignesh
    Elliott, Perry
    Gundapaneni, Balarama
    Li, Benjamin
    Sultan, Marla
    Grogan, Martha
    JOURNAL OF CARDIAC FAILURE, 2020, 26 (10) : S64 - S65
  • [5] Extrapolation of Survival Benefits in Patients with Transthyretin Amyloid Cardiomyopathy Receiving Tafamidis: Analysis of the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial
    Li, Benjamin
    Alvir, Jose
    Stewart, Michelle
    CARDIOLOGY AND THERAPY, 2020, 9 (02) : 535 - 540
  • [6] Extrapolation of Survival Benefits in Patients with Transthyretin Amyloid Cardiomyopathy Receiving Tafamidis: Analysis of the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial
    Benjamin Li
    Jose Alvir
    Michelle Stewart
    Cardiology and Therapy, 2020, 9 : 535 - 540
  • [7] Long-Term Effect of Tafamidis on Clinical Parameters and Prognostic Predictors in Patients With Transthyretin Amyloid Cardiomyopathy
    Kuyama, Naoto
    Izumiya, Yasuhiro
    Takashio, Seiji
    Usuku, Hiroki
    Tabira, Akihisa
    Oguni, Tetsuya
    Yamamoto, Masahiro
    Hirakawa, Kyoko
    Ishii, Masanobu
    Tabata, Noriaki
    Hoshiyama, Tadashi
    Kanazawa, Hisanori
    Hanatani, Shinsuke
    Kidoh, Masafumi
    Oda, Seitaro
    Matsuzawa, Yasushi
    Yamamoto, Eiichiro
    Hirai, Toshinori
    Ueda, Mitsuharu
    Tsujita, Kenichi
    CIRCULATION JOURNAL, 2025, 89 (04) : 421 - 431
  • [8] Efficacy and safety of tafamidis doses in the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR-ACT) and long-term extension study
    Damy, Thibaud
    Garcia-Pavia, Pablo
    Hanna, Mazen
    Judge, Daniel P.
    Merlini, Giampaolo
    Gundapaneni, Balarama
    Patterson, Terrell A.
    Riley, Steven
    Schwartz, Jeffrey H.
    Sultan, Marla B.
    Witteles, Ronald
    EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 (02) : 277 - 285
  • [9] Impact of Tafamidis on Health-Related Quality of Life in Patients With Transthyretin Amyloid Cardiomyopathy (from the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial)
    Hanna, Mazen
    Damy, Thibaud
    Grogan, Martha
    Stewart, Michelle
    Gundapaneni, Balarama
    Patterson, Terrell A.
    Schwartz, Jeffrey H.
    Sultan, Marla B.
    Maurer, Mathew S.
    AMERICAN JOURNAL OF CARDIOLOGY, 2021, 141 : 98 - 105
  • [10] Long-term tafamidis efficacy in patients with transthyretin amyloid cardiomyopathy by baseline left ventricular ejection fraction
    Drachman, Brian
    Damy, Thibaud
    Hanna, Mazen
    Wang, Ronnie
    Angeli, Franca S.
    Garcia-Pavia, Pablo
    EUROPEAN JOURNAL OF HEART FAILURE, 2024, 26 (09) : 2038 - 2046
12345